See more : COSCO SHIPPING Holdings Co., Ltd. (601919.SS) Income Statement Analysis – Financial Results
Complete financial analysis of PT Siloam International Hospitals Tbk (SILO.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Siloam International Hospitals Tbk, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Ching Feng Home Fashions Co.,Ltd (9935.TW) Income Statement Analysis – Financial Results
- CHP Merger Corp. (CHPMW) Income Statement Analysis – Financial Results
- Aether Industries Limited (AETHER.BO) Income Statement Analysis – Financial Results
- Rockcliff Metals Corporation (RKCLF) Income Statement Analysis – Financial Results
- UOL Group Limited (U14.SI) Income Statement Analysis – Financial Results
PT Siloam International Hospitals Tbk (SILO.JK)
About PT Siloam International Hospitals Tbk
PT Siloam International Hospitals Tbk, together with its subsidiaries, provides healthcare services in Indonesia. It also engages in setting up and managing hospitals. The company offers specialist and general medical services, including complex surgical procedures, laboratory services, radiology and imaging services, diagnostic, and emergency services. Its hospitals provide services in the areas of pediatrics, neurology, ENT, general surgery, emergency, nephrology, cardiology, oncology, obstetrics and gynecology, gastroenterology, ophthalmology, pulmonology, internal medicines, orthopedics, urology, anesthesiology, dentistry, dermatology, geriatric and nuclear medicines, pathology, plastic surgery, and psychiatry. The company operates 40 hospitals with 8,450 beds in Sumatra, Java, Bali, Kalimantan, Sulawesi, Nusa Tenggara Timur, Nusa Tenggara Barat, and Bangka. In addition, it engages in trading, development, mining, agriculture, service, land transportation, industry, workshop printing, plantation, forestry, electrical, mechanical, engineering, construction, agribusiness, and real estate businesses; computer programming activities; provision of management consulting, trust, financing, financial entities, retail, professional, and scientific and technical activities; and web portal and/or digital platform business. The company was formerly known as PT Sentralindo Wirasta. PT Siloam International Hospitals Tbk was founded in 1996 and is headquartered in Tangerang, Indonesia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11,190.51B | 9,518.01B | 9,381.89B | 7,110.12B | 7,017.92B | 5,964.65B | 5,848.01B | 5,168.36B | 4,144.12B | 3,340.79B | 2,503.60B | 1,788.08B | 1,259.35B | 1,030.47B |
| Cost of Revenue | 6,942.77B | 5,984.62B | 5,764.95B | 4,779.19B | 4,818.02B | 4,035.80B | 4,196.88B | 3,646.20B | 2,967.57B | 2,388.73B | 1,844.90B | 1,343.27B | 925.76B | 772.92B |
| Gross Profit | 4,247.75B | 3,533.39B | 3,616.94B | 2,330.93B | 2,199.90B | 1,928.86B | 1,651.13B | 1,522.17B | 1,176.55B | 952.06B | 658.70B | 444.81B | 333.58B | 257.55B |
| Gross Profit Ratio | 37.96% | 37.12% | 38.55% | 32.78% | 31.35% | 32.34% | 28.23% | 29.45% | 28.39% | 28.50% | 26.31% | 24.88% | 26.49% | 24.99% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2,286.12B | 629.16B | 684.52B | 440.78B | 618.94B | 541.71B | 442.39B | 430.62B | 351.95B | 318.69B | 240.01B | 140.14B | 78.39B | 58.75B |
| Selling & Marketing | 120.32B | 87.73B | 62.87B | 14.18B | 51.63B | 49.07B | 52.06B | 44.76B | 21.38B | 16.84B | 16.11B | 8.86B | 3.73B | 2.37B |
| SG&A | 2,369.05B | 716.89B | 747.38B | 454.96B | 670.57B | 590.78B | 494.44B | 475.38B | 373.33B | 335.53B | 256.12B | 149.00B | 82.11B | 61.12B |
| Other Expenses | 150.42B | 1,667.33B | 1,699.77B | 1,332.77B | 1,411.13B | -106.86B | -77.70B | -69.92B | -53.16B | -34.26B | 323.89B | 14.52B | -17.36B | 3.26B |
| Operating Expenses | 2,519.46B | 2,384.22B | 2,447.15B | 1,787.72B | 2,081.70B | 1,630.34B | 1,354.13B | 1,230.55B | 965.32B | 783.95B | 580.01B | 367.86B | 245.06B | 156.90B |
| Cost & Expenses | 9,462.23B | 8,368.84B | 8,212.10B | 6,566.92B | 6,899.72B | 5,666.13B | 5,551.02B | 4,876.75B | 3,932.90B | 3,172.68B | 2,424.92B | 1,711.13B | 1,170.82B | 929.82B |
| Interest Income | 21.98B | 29.92B | 19.15B | 11.25B | 3.13B | 15.78B | 20.46B | 2.59B | 4.98B | 15.43B | 12.02B | 3.58B | 2.76B | 366.37M |
| Interest Expense | 83.76B | 38.33B | 37.92B | 71.09B | 27.54B | 21.76B | 21.25B | 31.51B | 40.24B | 37.45B | 6.92B | 18.03B | 16.19B | 10.71B |
| Depreciation & Amortization | 942.30B | 961.95B | 950.43B | 806.83B | 545.86B | 497.90B | 428.38B | 365.93B | 101.66B | 80.77B | 52.48B | 31.92B | 22.08B | 5.58B |
| EBITDA | 2,692.46B | 2,014.12B | 1,988.28B | 1,208.65B | 448.72B | 705.41B | 626.93B | 581.34B | 495.03B | 413.34B | 281.17B | 117.53B | 96.01B | 109.86B |
| EBITDA Ratio | 24.06% | 19.50% | 19.84% | 12.52% | 4.44% | 6.64% | 6.13% | 5.97% | 5.98% | 6.34% | 5.24% | 7.10% | 7.62% | 10.66% |
| Operating Income | 1,728.29B | 1,022.33B | 1,018.70B | 390.59B | 38.48B | 191.65B | 219.29B | 221.70B | 158.07B | 133.85B | 78.68B | 91.47B | 71.17B | 103.91B |
| Operating Income Ratio | 15.44% | 10.74% | 10.86% | 5.49% | 0.55% | 3.21% | 3.75% | 4.29% | 3.81% | 4.01% | 3.14% | 5.12% | 5.65% | 10.08% |
| Total Other Income/Expenses | -61.88B | -38.03B | -45.84B | -79.94B | -49.26B | -25.50B | -19.25B | -49.40B | -52.32B | -40.35B | -6.92B | -14.45B | -13.43B | -10.34B |
| Income Before Tax | 1,666.41B | 984.31B | 972.87B | 310.65B | -149.54B | 166.16B | 200.04B | 172.29B | 105.75B | 93.51B | 71.76B | 77.02B | 57.74B | 93.57B |
| Income Before Tax Ratio | 14.89% | 10.34% | 10.37% | 4.37% | -2.13% | 2.79% | 3.42% | 3.33% | 2.55% | 2.80% | 2.87% | 4.31% | 4.58% | 9.08% |
| Income Tax Expense | 419.37B | 273.93B | 272.68B | 185.40B | 183.46B | 139.76B | 96.52B | 73.59B | 44.04B | 33.80B | 21.57B | 25.06B | 19.86B | 21.70B |
| Net Income | 1,211.28B | 696.50B | 674.12B | 116.16B | -333.00B | 16.18B | 93.57B | 85.90B | 70.40B | 62.57B | 49.87B | 50.46B | 43.74B | 67.48B |
| Net Income Ratio | 10.82% | 7.32% | 7.19% | 1.63% | -4.74% | 0.27% | 1.60% | 1.66% | 1.70% | 1.87% | 1.99% | 2.82% | 3.47% | 6.55% |
| EPS | 93.27 | 70.74 | 52.12 | 8.94 | -25.60 | 1.24 | 8.54 | 9.06 | 7.47 | 7.60 | 5.82 | 6.17 | 5.35 | 17.52 |
| EPS Diluted | 92.92 | 70.59 | 52.02 | 8.94 | -25.60 | 1.24 | 8.54 | 9.06 | 7.47 | 7.60 | 5.82 | 6.17 | 5.35 | 17.52 |
| Weighted Avg Shares Out | 12.99B | 9.85B | 12.93B | 12.99B | 13.01B | 13.01B | 10.96B | 9.48B | 9.42B | 9.25B | 8.38B | 8.00B | 8.18B | 3.85B |
| Weighted Avg Shares Out (Dil) | 13.04B | 9.87B | 12.96B | 12.99B | 13.01B | 13.01B | 10.96B | 9.48B | 9.42B | 9.46B | 8.56B | 8.18B | 8.18B | 3.85B |
Source: https://incomestatements.info
Category: Stock Reports